1. A composition comprising a therapeutically effective amount of an extract from a Terminalia elliptica plant as an active ingredient together with at least one pharmaceutically acceptable carrier. A composition according to claim 1, characterized in that said composition contains 5-100% extract from a plant of Terminalia elliptica. 3. A composition according to claim 1, characterized in that the extract is obtained from the bark of a Terminalia elliptica plant. 4. A composition according to claim 1, characterized in that the extract from the Terminalia elliptica plant contains a biologically active marker together with at least one pharmaceutically acceptable carrier. A composition according to claim 4, characterized in that the biologically active marker is ellagic acid, 4-O-alpha-L-rhamnopyranoside (compound 1) .6. A composition according to claim 1, characterized in that the extract from the Terminalia elliptica plant contains from 0.01 to 10.0% of compound 1 as a biologically active marker. A composition according to claim 1, characterized in that said composition is administered orally to a subject in need of treatment for metabolic disorders. A composition according to claim 7, characterized in that the composition is formulated for oral administration in the form of a tablet, capsule or granules. A composition according to claim 1 for use in the treatment of metabolic disorders. The composition for use according to claim 9, characterized in that the metabolic disorder is selected from insulin resistance, hyperglycemia, diabetes mellitus, obesity, impaired glucose tolerance, hypercholesterolemia, dyslipidemia, hyperinsulinemia, atherosclerotic disease, polycystic ovary syndrome, coronary artery disease a syndrome, hypertension, or a related disorder associated with abnormal plasma lipoprotein, triglycerides, or a disorder,1. Композиция, содержащая терапевтически эффективное количество экстракта из растения Terminalia elliptica в качестве активного ингредиент
